|
BE585507A
(OSRAM)
|
1960-03-31 |
|
|
|
|
US3297710A
(en)
|
1963-04-09 |
1967-01-10 |
Du Pont |
Oxoarylidene-imidazoles
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US3714181A
(en)
|
1970-12-31 |
1973-01-30 |
American Cyanamid Co |
2-aryl-5,10-diphenylphenanthro(9,10-d)azoles
|
|
US4089747A
(en)
|
1976-08-09 |
1978-05-16 |
Eastman Kodak Company |
Compositions for the detection of hydrogen peroxide
|
|
CA1178414A
(en)
|
1978-02-08 |
1984-11-27 |
Toyo Boseki Kabushiki Kaisha (Trading Under The Name Of Toyobo Co., Ltd.) |
Packaging material having excellent seal packaging property
|
|
US4233402A
(en)
|
1978-04-05 |
1980-11-11 |
Syva Company |
Reagents and method employing channeling
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
|
US4535058A
(en)
|
1982-10-01 |
1985-08-13 |
Massachusetts Institute Of Technology |
Characterization of oncogenes and assays based thereon
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
DE3141063A1
(de)
|
1981-10-13 |
1983-04-28 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
|
|
US4423046A
(en)
|
1982-04-05 |
1983-12-27 |
Sterling Drug Inc. |
Antibacterial and antiprotozoal 1-methyl-5-nitro-2-(2-phenylvinyl)imidazoles
|
|
US4659678A
(en)
|
1982-09-29 |
1987-04-21 |
Serono Diagnostics Limited |
Immunoassay of antigens
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
US4727022A
(en)
|
1984-03-14 |
1988-02-23 |
Syntex (U.S.A.) Inc. |
Methods for modulating ligand-receptor interactions and their application
|
|
DE3422175A1
(de)
|
1984-06-04 |
1985-12-19 |
Julius Dr. 8000 München Kern |
Verfahren zur beimischung von ammoniak zu saure schadstoffe enthaltenden abgasen oder luft
|
|
JPS614960A
(ja)
|
1984-06-19 |
1986-01-10 |
Fuji Photo Film Co Ltd |
分析試薬および多層化学分析要素
|
|
US4762706A
(en)
|
1984-10-17 |
1988-08-09 |
Cetus Corporation |
Peptide antibodies and their use in detecting oncogene products
|
|
US5081230A
(en)
|
1987-07-08 |
1992-01-14 |
E. I. Dupont Denemours And Company |
Monoclonal antibodies reactive with normal and oncogenic forms of the ras p21 protein
|
|
US5443956A
(en)
|
1985-01-29 |
1995-08-22 |
Oncogene Science, Inc. |
Detection, quantitation and classification of RAS proteins in body fluids and tissues
|
|
US4720459A
(en)
|
1985-02-14 |
1988-01-19 |
Medical College Of Wisconsin Research Foundation, Inc. |
Myelomas for producing human/human hybridomas
|
|
US4758421A
(en)
|
1985-03-15 |
1988-07-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Bleomycin conjugates and method
|
|
IT1214597B
(it)
|
1985-04-15 |
1990-01-18 |
Rorer Italiana Spa |
Derivati dell'imidazolo adattivita' antimicotica, procedimento ed intermedi per laloro preparazione e composizioni che li contengono.
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
EP0248086B1
(en)
|
1985-12-12 |
1993-03-17 |
Ube Industries, Ltd. |
Imidazole derivatives, bactericides containing them, and process for their preparation
|
|
GB8607683D0
(en)
|
1986-03-27 |
1986-04-30 |
Ici Plc |
Anti-tumor agents
|
|
US5024935A
(en)
|
1987-12-18 |
1991-06-18 |
Eastman Kodak Company |
Dye-providing composition, diagnostic test kit and their use in method for ligand determination using peroxidase labeled-receptor
|
|
US5047318A
(en)
|
1988-06-13 |
1991-09-10 |
Eastman Kodak Company |
Imidazole leuco dye composition containing 4'-hydroxyacetanilide, diagnostic kit and method using same
|
|
US5011472A
(en)
|
1988-09-06 |
1991-04-30 |
Brown University Research Foundation |
Implantable delivery system for biological factors
|
|
US5501959A
(en)
|
1989-01-17 |
1996-03-26 |
Alamar Biosciences Laboratory, Inc. |
Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents
|
|
US5514550A
(en)
|
1989-02-03 |
1996-05-07 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Nucleic acid test article and its use to detect a predetermined nucleic acid
|
|
ATE122256T1
(de)
|
1989-03-08 |
1995-05-15 |
Rocky Research |
Vorrichtung und verfahren zur erhaltung von hohen reaktionsleistungen in fest-gas-reaktorsystemen.
|
|
US5441716A
(en)
|
1989-03-08 |
1995-08-15 |
Rocky Research |
Method and apparatus for achieving high reaction rates
|
|
JPH02258017A
(ja)
|
1989-03-31 |
1990-10-18 |
Babcock Hitachi Kk |
固体還元剤を用いた排ガス脱硝装置
|
|
US5744101A
(en)
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
|
US4970226A
(en)
|
1989-10-03 |
1990-11-13 |
Harbor Branch Oceanographic Institution, Inc. |
Bis-indole imidazole compounds which are useful antitumor and antimicrobial agents
|
|
US5161389A
(en)
|
1990-11-13 |
1992-11-10 |
Rocky Research |
Appliance for rapid sorption cooling and freezing
|
|
FI941572L
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
|
|
US5656644A
(en)
|
1994-07-20 |
1997-08-12 |
Smithkline Beecham Corporation |
Pyridyl imidazoles
|
|
US5916891A
(en)
|
1992-01-13 |
1999-06-29 |
Smithkline Beecham Corporation |
Pyrimidinyl imidazoles
|
|
MX9300141A
(es)
|
1992-01-13 |
1994-07-29 |
Smithkline Beecham Corp |
Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
|
|
EP1997894B1
(en)
|
1992-02-06 |
2011-03-30 |
Novartis Vaccines and Diagnostics, Inc. |
Biosynthetic binding protein for cancer marker
|
|
US6177401B1
(en)
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
|
WO1995003297A1
(en)
|
1993-07-21 |
1995-02-02 |
Smithkline Beecham Corporation |
Imidazoles for treating cytokine mediated disease
|
|
IL112248A0
(en)
|
1994-01-25 |
1995-03-30 |
Warner Lambert Co |
Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
|
|
US5496702A
(en)
|
1994-09-01 |
1996-03-05 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Immunoassay elements having stable leuco dye coatings
|
|
US5473057A
(en)
|
1994-11-09 |
1995-12-05 |
The Regents Of The University Of California |
Eleutherobin and analogs thereof
|
|
AU4301096A
(en)
|
1994-12-13 |
1996-07-03 |
F. Hoffmann-La Roche Ag |
Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
|
|
TW424172B
(en)
|
1995-04-19 |
2001-03-01 |
Hitachi Chemical Co Ltd |
Photosensitive resin composition and photosensitive element using the same
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
US5880141A
(en)
|
1995-06-07 |
1999-03-09 |
Sugen, Inc. |
Benzylidene-Z-indoline compounds for the treatment of disease
|
|
US5700826A
(en)
|
1995-06-07 |
1997-12-23 |
Ontogen Corporation |
1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance
|
|
US5753687A
(en)
|
1995-06-19 |
1998-05-19 |
Ontogen Corporation |
Modulators of proteins with phosphotryrosine recognition units
|
|
GB9520822D0
(en)
|
1995-10-11 |
1995-12-13 |
Wellcome Found |
Therapeutically active compounds
|
|
GB9624482D0
(en)
|
1995-12-18 |
1997-01-15 |
Zeneca Phaema S A |
Chemical compounds
|
|
AU719327B2
(en)
|
1996-03-05 |
2000-05-04 |
Astrazeneca Ab |
4-anilinoquinazoline derivatives
|
|
AU727939B2
(en)
|
1996-04-03 |
2001-01-04 |
Merck & Co., Inc. |
A method of treating cancer
|
|
US5693589A
(en)
|
1996-05-08 |
1997-12-02 |
Eastman Kodak Company |
Thermal imaging recording element
|
|
EP0812829A1
(en)
|
1996-06-14 |
1997-12-17 |
Ontogen Corporation |
Substituted imidazoles as modulators of multi-drug resistance
|
|
AR007857A1
(es)
|
1996-07-13 |
1999-11-24 |
Glaxo Group Ltd |
Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios uso en medicina ycomposiciones farmaceuticas que los contienen.
|
|
ID19430A
(id)
|
1996-07-13 |
1998-07-09 |
Glaxo Group Ltd |
Senyawa senyawa heterosiklik
|
|
IT240917Y1
(it)
|
1996-10-01 |
2001-04-11 |
Stefcom Spa |
Scarpa con tomaia avente porzione per la traspirazione dell'internodella scarpa
|
|
ID18494A
(id)
|
1996-10-02 |
1998-04-16 |
Novartis Ag |
Turunan pirazola leburan dan proses pembuatannya
|
|
EP0946587A2
(en)
|
1996-12-16 |
1999-10-06 |
Fujisawa Pharmaceutical Co., Ltd. |
New amide compounds
|
|
JP2001506997A
(ja)
|
1996-12-16 |
2001-05-29 |
オントジエン・コーポレイシヨン |
ホスホチロシン認識ユニットを有する蛋白質の修飾物質
|
|
US5945418A
(en)
|
1996-12-18 |
1999-08-31 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
US5809775A
(en)
|
1997-04-02 |
1998-09-22 |
Clean Diesel Technologies, Inc. |
Reducing NOx emissions from an engine by selective catalytic reduction utilizing solid reagents
|
|
PT1028954E
(pt)
|
1997-04-24 |
2003-11-28 |
Ortho Mcneil Pharm Inc |
Imidazoles substituidos uteis no tratamento de doencas inflamatorias
|
|
WO1998050356A1
(en)
|
1997-05-07 |
1998-11-12 |
Sugen, Inc. |
2-indolinone derivatives as modulators of protein kinase activity
|
|
JPH10319584A
(ja)
|
1997-05-21 |
1998-12-04 |
Brother Ind Ltd |
マイクロカプセルを用いた感光性記録材料
|
|
EP0984692A4
(en)
|
1997-05-30 |
2001-02-21 |
Merck & Co Inc |
ANGIOGENESIS INHIBITORS
|
|
IL133731A0
(en)
|
1997-07-03 |
2001-04-30 |
Neurogen Corp |
Certain diarylimidazole derivatives, a new class of npy specific ligands
|
|
DE19728343C5
(de)
|
1997-07-03 |
2013-02-21 |
Robert Bosch Gmbh |
Verfahren und Vorrichtung zur selektiven katalytischen NOx-Reduktion
|
|
US5840721A
(en)
|
1997-07-09 |
1998-11-24 |
Ontogen Corporation |
Imidazole derivatives as MDR modulators
|
|
AU8689298A
(en)
|
1997-08-05 |
1999-03-01 |
Sugen, Inc. |
Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors
|
|
DE69838172T2
(de)
|
1997-08-22 |
2008-04-10 |
Astrazeneca Ab |
Oxindolylchinazolinderivate als angiogenesehemmer
|
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
|
BR9814018A
(pt)
|
1997-11-11 |
2000-09-26 |
Pfizer Prod Inc |
Derivados de tienopirimidina e tienopiridina úteis como agentes anticâncer
|
|
JPH11199582A
(ja)
|
1998-01-05 |
1999-07-27 |
Sagami Chem Res Center |
４（５）−（３−インドリル）イミダゾール誘導体
|
|
GB9800569D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
|
GB9800575D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
|
US6589966B1
(en)
|
1998-03-18 |
2003-07-08 |
Wake Forest University Health Sciences |
Cytotoxic metal chelators and methods for making and using same
|
|
IL139934A
(en)
|
1998-05-29 |
2007-10-31 |
Sugen Inc |
History 2 - Indulinone converted to pyrrole and pharmaceutical preparations containing them
|
|
US6288212B1
(en)
|
1998-08-28 |
2001-09-11 |
The University Of British Columbia |
Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
|
|
WO2000033836A1
(en)
|
1998-12-04 |
2000-06-15 |
Ontogen Corporation |
5-membered heterocycles for the treatment of human diseases involving modulators of selectins
|
|
JP2000273088A
(ja)
|
1999-01-18 |
2000-10-03 |
Nippon Soda Co Ltd |
トリフェニルイミダゾール化合物および農園芸用殺菌剤
|
|
JP2000281588A
(ja)
|
1999-03-30 |
2000-10-10 |
Sankyo Co Ltd |
ガンの予防又は治療薬及びそのスクリーニング方法
|
|
DE19920936A1
(de)
|
1999-05-07 |
2000-11-09 |
Basf Ag |
Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung
|
|
AU4640600A
(en)
|
1999-05-11 |
2000-11-21 |
Eli Lilly And Company |
Amyloid precursor protein protease and related nucleic acid compounds
|
|
US7364868B2
(en)
|
1999-05-19 |
2008-04-29 |
The Uab Research Foundation |
Krüppel-like transcriptional factor KLF4/GKLF and uses thereof
|
|
DE19925631A1
(de)
|
1999-06-04 |
2000-12-07 |
Georg Gros |
Beschichtungsverfahren und Beschichtungsgemisch
|
|
WO2000078761A1
(en)
|
1999-06-23 |
2000-12-28 |
Sepracor, Inc. |
Indolyl-benzimidazole antibacterials, and methods of use thereof
|
|
TWI262914B
(en)
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
|
US6266955B1
(en)
|
1999-08-20 |
2001-07-31 |
Caterpillar Inc. |
Diagnostic system for an emissions control on an engine
|
|
CN1087744C
(zh)
|
1999-09-24 |
2002-07-17 |
中国科学院化学研究所 |
一种钌（ⅱ）多吡啶配合物及其制备方法
|
|
CN1088713C
(zh)
|
1999-09-24 |
2002-08-07 |
中国科学院化学研究所 |
用于二级pH传感的钌（Ⅱ）多吡啶配合物及其制备方法
|
|
AU782401B2
(en)
|
1999-10-08 |
2005-07-28 |
Taiji Biomedical, Inc. |
Methods of enhancing chemotherapy
|
|
US7115645B2
(en)
|
2000-01-14 |
2006-10-03 |
Schering Aktiengesellschaft |
1,2 diarylbenzimidazoles and their pharmaceutical use
|
|
WO2001073133A1
(en)
|
2000-03-27 |
2001-10-04 |
Thomas Jefferson University |
Compositions and methods for identifying and targeting cancer cells
|
|
EP1309726B2
(en)
|
2000-03-30 |
2018-10-03 |
Whitehead Institute For Biomedical Research |
Rna sequence-specific mediators of rna interference
|
|
EP1318992B1
(en)
|
2000-09-21 |
2005-07-27 |
Smithkline Beecham Plc |
Imidazole derivatives as raf kinase inhibitors
|
|
AU2002211725B2
(en)
|
2000-10-13 |
2005-06-30 |
Vion Pharmaceuticals, Inc. |
Modified prodrug forms of AP/AMP
|
|
US20070004713A1
(en)
|
2000-12-07 |
2007-01-04 |
Bernard Barlaam |
Therapeutic benimidazole compounds
|
|
MXPA03008142A
(es)
|
2001-03-09 |
2003-12-12 |
Pfizer Prod Inc |
Nuevos compuestos antiinflamatorios de bencimidazol.
|
|
JP2002275458A
(ja)
|
2001-03-21 |
2002-09-25 |
Fukuoka Prefecture |
フォトクロミックアモルファス材料及び高密度光記録媒体
|
|
IL158168A0
(en)
|
2001-04-16 |
2004-03-28 |
Tanabe Seiyaku Co |
5-membered, nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same
|
|
US6939499B2
(en)
|
2001-05-31 |
2005-09-06 |
3M Innovative Properties Company |
Processes and apparatus for making transversely drawn films with substantially uniaxial character
|
|
JP3759882B2
(ja)
|
2001-06-01 |
2006-03-29 |
株式会社日立製作所 |
ポンプ装置
|
|
DE10134775A1
(de)
|
2001-07-06 |
2003-01-30 |
Schering Ag |
1-Alkyl-2.aryl-benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
|
|
US7695926B2
(en)
|
2001-07-10 |
2010-04-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for detecting receptor-ligand interactions in single cells
|
|
WO2003011285A1
(en)
|
2001-08-01 |
2003-02-13 |
Merck & Co., Inc. |
BENZIMIDAZO[4,5-f]ISOQUINOLINONE DERIVATIVES
|
|
BR0206161A
(pt)
|
2001-10-19 |
2005-02-01 |
Ortho Mcneil Pharm Inc |
2-fenil benzimidazóis e imidazo-[4,5]-piridinas como inibidores de cds1/chk2 e adjuvantes para quimioterapia ou terapia por radiação no tratamento de câncer
|
|
US20040091951A1
(en)
|
2002-02-07 |
2004-05-13 |
Axys Pharmaceuticals, Inc. |
Assay for measuring acetylation or deacetylation activity of an enzyme
|
|
US6790852B2
(en)
|
2002-04-18 |
2004-09-14 |
Hoffmann-La Roche Inc. |
2-(2,6-dichlorophenyl)-diarylimidazoles
|
|
KR100653662B1
(ko)
|
2002-06-19 |
2006-12-05 |
쿠리타 고교 가부시키가이샤 |
수소 저장 방법, 수소 포접 화합물 및 그 제조 방법
|
|
EP1532118A2
(en)
|
2002-07-05 |
2005-05-25 |
Axxima Pharmaceuticals Aktiengesellschaft |
Imidazole compounds for the treatment of hepatitis c virus infections
|
|
AU2003257329C1
(en)
|
2002-08-19 |
2010-07-22 |
Lorus Therapeutics Inc. |
2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
|
|
DE10251472A1
(de)
|
2002-11-06 |
2004-05-19 |
Robert Bosch Gmbh |
Verfahren zur Nachbehandlung von Abgasen und Anordnung hierzu
|
|
WO2004071464A2
(en)
*
|
2003-02-12 |
2004-08-26 |
Johns Hopkins University School Of Medicine |
Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells
|
|
US7989089B2
(en)
|
2003-04-17 |
2011-08-02 |
Lg Display Co., Ltd. |
Organic luminescent compounds and methods of making and using same
|
|
CA2425797C
(en)
|
2003-04-17 |
2013-10-15 |
Xerox Corporation |
Organic light emitting devices
|
|
DE10323591A1
(de)
|
2003-05-16 |
2004-12-02 |
E.G.O. Elektro-Gerätebau GmbH |
Verfahren und Vorrichtung zur Erzeugung eines Gases aus einem Sublimationsgut
|
|
CA2545942C
(en)
*
|
2003-11-14 |
2012-07-10 |
Lorus Therapeutics Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
|
US20050186642A1
(en)
|
2004-02-24 |
2005-08-25 |
Biocare Medical, Inc. |
Immunoassay reagents and methods of use thereof
|
|
US20050195793A1
(en)
|
2004-03-05 |
2005-09-08 |
Lockheed Martin Corporation |
System for locally synchronizing a group of mobile devices
|
|
US20050282285A1
(en)
|
2004-06-21 |
2005-12-22 |
Eaton Corporation |
Strategy for controlling NOx emissions and ammonia slip in an SCR system using a nonselective NOx/NH3
|
|
JP2008508186A
(ja)
|
2004-08-03 |
2008-03-21 |
アムミネクス・アー／エス |
固体アンモニア貯蔵及び移送材料
|
|
KR20070100786A
(ko)
|
2005-02-03 |
2007-10-11 |
아미넥스 에이/에스 |
암모니아의 고밀도 저장
|
|
JP5334575B2
(ja)
*
|
2005-05-25 |
2013-11-06 |
ローラス セラピューティクス インコーポレーテッド |
２−インドリルイミダゾ［４，５‐ｄ］フェナントロリン派生物および癌治療におけるそれらの使用
|
|
WO2006126177A2
(en)
|
2005-05-25 |
2006-11-30 |
Genesense Technologies Inc. |
2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
|
|
WO2007000170A1
(en)
|
2005-06-29 |
2007-01-04 |
Amminex A/S |
Method and device for safe and controlled delivery of ammonia from a solid ammonia storage medium
|
|
KR100694181B1
(ko)
|
2005-11-25 |
2007-03-12 |
연세대학교 산학협력단 |
근원세포 또는 근섬유로부터 신경세포 분화를 유도하는화합물, 이를 포함하는 약학적 조성물, 신경세포 분화를유도하는 방법 및 신경세포 분화를 유도하는 화합물을검색하는 스크리닝 방법
|
|
DK3207941T6
(da)
*
|
2006-09-07 |
2020-11-09 |
Scott & White Memorial Hospital |
Fremgangsmåder og sammensætninger baseret på diphtheritoksin-interleukin-3-konjugater
|
|
WO2008125883A1
(en)
*
|
2007-04-16 |
2008-10-23 |
Cancer Research Technology Limited |
Cancer markers for prognosis and screening of anti-cancer agents
|
|
WO2008129080A1
(en)
*
|
2007-04-24 |
2008-10-30 |
Ingenium Pharmaceuticals Gmbh |
4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
|
|
CA2742252A1
(en)
|
2007-11-01 |
2009-05-07 |
Celgene Corporation |
Cytidine analogs for treatment of myelodysplastic syndromes
|
|
WO2009151503A2
(en)
|
2008-04-10 |
2009-12-17 |
University Of Florida Research Foundation, Inc. |
Compositions and methods for the treatment of a neoplasia
|
|
JP5340265B2
(ja)
|
2008-06-27 |
2013-11-13 |
国立大学法人京都大学 |
効率的な人工多能性幹細胞の樹立方法
|
|
US8399206B2
(en)
|
2008-07-10 |
2013-03-19 |
Nodality, Inc. |
Methods for diagnosis, prognosis and methods of treatment
|
|
WO2010102393A1
(en)
*
|
2009-03-12 |
2010-09-16 |
Lorus Therapeutics Inc. |
2-indolyl imidazo [4,5-d]phenanthroline derivatives and their use to inhibit angiogenesis
|
|
ES2413255T3
(es)
*
|
2009-04-09 |
2013-07-16 |
Lga Biotecnologie Srl |
Determinación de la eficacia de 5-ASA en la prevención y/o el tratamiento de CRC mediante el análisis de la expresión génica
|
|
JP5748653B2
(ja)
|
2009-04-10 |
2015-07-15 |
協和発酵キリン株式会社 |
抗ｔｉｍ−３抗体を用いた血液腫瘍治療法
|
|
US20120251509A1
(en)
|
2009-10-22 |
2012-10-04 |
Waldman Scott A |
Cell-based anti-cancer compositions and methods of making and using the same
|
|
US8524240B2
(en)
*
|
2009-10-26 |
2013-09-03 |
Djordje Atanackovic |
Diagnosis and therapy of hematological malignancies
|
|
WO2011085134A2
(en)
|
2010-01-06 |
2011-07-14 |
Georgetown University |
Methods and compositions for the diagnosis, prognosis and treatment of cancer
|
|
KR101317513B1
(ko)
|
2010-05-17 |
2013-10-15 |
가톨릭대학교 산학협력단 |
대장암 또는 난소암 진단용 조성물, 진단키트 및 진단방법
|
|
AU2011276590A1
(en)
*
|
2010-06-28 |
2013-01-31 |
Threshold Pharmaceuticals, Inc. |
Treatment of blood cancer
|
|
US20120172244A1
(en)
*
|
2010-12-20 |
2012-07-05 |
Steven Buechler |
Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease
|
|
ES2867924T3
(es)
*
|
2011-12-09 |
2021-10-21 |
Adaptive Biotechnologies Corp |
Diagnóstico de tumores malignos linfoides y detección de enfermedad residual mínima
|
|
TW201343920A
(zh)
*
|
2012-03-29 |
2013-11-01 |
Nat Health Research Institutes |
預測前列腺癌預後之分子標記、方法與套組
|
|
ES2775579T3
(es)
|
2013-10-04 |
2020-07-27 |
Aptose Biosciences Inc |
Composiciones para el tratamiento del cáncer
|
|
US20180163271A1
(en)
|
2014-01-16 |
2018-06-14 |
Clovis Oncology, Inc. |
Use of PARP Inhibitors to Treat Breast or Ovarian Cancer Patients Showing a Loss of Heterozygosity
|
|
AU2018360477A1
(en)
|
2017-10-30 |
2020-06-04 |
Aptose Biosciences Inc. |
Aryl imidazoles for the treatment of cancer
|